Low adiponectin levels at baseline and decreasing adiponectin levels over 10Â years of follow-up predict risk of the metabolic syndrome

Low plasma adiponectin levels at baseline and decreasing adiponectin levels during follow-up are both associated with an increased risk of MetS.